Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c03548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Ryann A Joseph und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, CRISPR-Cas Systems, CRISPR-Associated Protein 9. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: American Cancer Society Research Scholar Grant, NSF CAREER Award, Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Lipid nanoparticles (LNPs) are currently one of the most clinically advanced delivery systems for nucleic acid cargo and hold great potential for clinical applications in gene editing and the treatment of genetic diseases. LNP-mediated delivery of Cas9 with single guide RNA (sgRNA) and homology-directed repair DNA template (ssDNA) enables efficient and precise editing in vitro and in vivo. Comparative analysis of LNP delivery of Cas9 as protein or mRNA for relevant clinical targets, such as cystic fibrosis (CF), which is caused by mutations in the CFTR gene, is imperative in the design of corrective therapeutics for genetic diseases. Here, we show that delivery of Cas9 protein LNPs outperforms Cas9 mRNA LNPs when evaluated for in vivo lung editing as well as corrective CRISPR/Cas9 editing and functional recovery of the CFTR protein. These results demonstrate the ability to optimize the use of CRISPR/Cas9 LNPs for cystic fibrosis applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Center for Fetal Research, Division of General, Thoracic, and Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, United States.
- Penn Institute for RNA Innovation, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
- Abramson Cancer Center, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
- Institute for Immunology, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
- Cardiovascular Institute, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, United States.
ORCID-Profile: Ryann A Joseph, Rebecca M Haley, Marshall S Padilla, Hannah M Yamagata, Michael J Mitchell
Förderung
- American Cancer Society Research Scholar Grant
- NSF CAREER Award
- Cystic Fibrosis Foundation
- National Science Foundation Graduate Research Fellowship Program
- University of Pennsylvania
- National Institute of Dental and Craniofacial Research
- Center for Undergraduate Research and Fellowships, University of Pennsylvania
- American Cancer Society
Zitieren
APA
Joseph, R. A., Haley, R. M., Padilla, M. S., Ricciardi, A. S., Yamagata, H. M., & Mitchell, M. J. (2025). Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c03548
Vancouver
Joseph RA, Haley RM, Padilla MS, Ricciardi AS, Yamagata HM, Mitchell MJ. Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c03548
BibTeX
@article{Joseph2025,
author = {Joseph, Ryann A and Haley, Rebecca M and Padilla, Marshall S and Ricciardi, Adele S and Yamagata, Hannah M and Mitchell, Michael J},
title = {Cas9 Protein Outperforms mRNA in Lipid Nanoparticle-Mediated CFTR Repair},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c03548}
}
EUVIMED